Sally Dowen

Sally joined HMR as a Clinical Project Manager in 2006, with responsibility for management of clinical trials, writing trial-related documents, ethics submissions, and preparing Clinical Trial Authorisation applications. In 2008, she became Senior Clinical Project Manager, with responsibility for training and providing support to Clinical Project Managers. We promoted her to Team Leader in 2010, giving her line management responsibility for the group. In 2014, we further promoted Sally to Head of Clinical Science, and in 2019, to Director, with responsibility for clinical project management, medical writing, and regulatory support. In 2021, she became the head of the projects division, with the title of Director of Clinical Science and Regulatory Affairs.

Sally gained an MA in Natural Sciences in 1998, and a PhD in Molecular Oncology in 2002, both from Cambridge University. She held Post-doctoral Research Associate positions at Cambridge University and Cancer Research UK between 2002 and 2006. In 2010 she gained a Certificate in Human Pharmacology from the Royal College of Physicians, Faculty of Pharmaceutical Medicine.